Reply to: “Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?”
Philippa C. Matthews(University College London Hospitals NHS Foundation Trust), Saeed Hamid(Aga Khan University), C Wendy Spearman(University of Cape Town), Angélica Espinosa Miranda(Ministério da Saúde), Fernando de la Hoz, Geoffrey Dusheiko(University of the Witwatersrand), Homie Razavi(Center for Disease Analysis), Calvin Q. Pan(New York University), Manal H. El‐Sayed(Ain Shams University), Robinson Enow Mbu(Université de Yaoundé I), Ponsiano Ocama(Makerere University), Judith Torimiro(Université de Yaoundé I), Deborah Ford(MRC Clinical Trials Unit at UCL), Emmanuel Seremba(Makerere University), Su Wang(Rutgers, The State University of New Jersey), Anna Turkova(Great Ormond Street Hospital)
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789